5yy4: Difference between revisions

← Older edit Newer edit →

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
-The entry 5yy4 is ON HOLD  until Paper Publication
+==Crystal structure of the scFv antibody 4B08 with sulfated epitope peptide==
+<StructureSection load='5yy4' size='340' side='right' caption='[[5yy4]], [[Resolution|resolution]] 1.59&Aring;' scene=''>
-Authors: Caaveiro, J.M.M., Miyanabe, K., Tsumoto, K.
+== Structural highlights ==
+<table><tr><td colspan='2'>[[5yy4]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YY4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YY4 FirstGlance]. <br>
-Description: Crystal structure of the scFv antibody 4B08 with sulfated epitope peptide
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-[[Category: Unreleased Structures]]
+<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=TYS:O-SULFO-L-TYROSINE'>TYS</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5yy4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5yy4 OCA], [http://pdbe.org/5yy4 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5yy4 RCSB], [http://www.ebi.ac.uk/pdbsum/5yy4 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5yy4 ProSAT]</span></td></tr>
+</table>
+== Disease ==
+[[http://www.uniprot.org/uniprot/CCR5_HUMAN CCR5_HUMAN]] Genetic variation in CCR5 is associated with susceptibility to diabetes mellitus insulin-dependent type 22 (IDDM22) [MIM:[http://omim.org/entry/612522 612522]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:19073967</ref>
+== Function ==
+[[http://www.uniprot.org/uniprot/CCR5_HUMAN CCR5_HUMAN]] Receptor for a number of inflammatory CC-chemokines including MIP-1-alpha, MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Acts as a coreceptor (CD4 being the primary receptor) for HIV-1 R5 isolates.<ref>PMID:8639485</ref> <ref>PMID:8663314</ref> <ref>PMID:8699119</ref> <ref>PMID:8649511</ref> <ref>PMID:8649512</ref> <ref>PMID:11323418</ref>
+== References ==
+<references/>
+__TOC__
+</StructureSection>
+[[Category: Caaveiro, J M.M]]
+[[Category: Miyanabe, K]]
 [[Category: Tsumoto, K]]
-[[Category: Caaveiro, J.M.M]]
+[[Category: Antibody]]
-[[Category: Miyanabe, K]]
+[[Category: Biomolecular recognition]]
+[[Category: Immune system]]
+[[Category: Md simulation]]
+[[Category: Thermodynamic]]